Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-891X
ISSN (Online): 2212-4071

Review Article

Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy

Author(s): Mohammad T. Athar* and Zabih Ullah

Volume 12, Issue 2, 2017

Page: [120 - 127] Pages: 8

DOI: 10.2174/1574891X12666170425122416

Price: $65

Abstract

Background: Tuberculosis (TB), which is caused by the Mycobacterium tuberculosis, is a serious threat and one of the major health problems worldwide.

Objective: In recent years, an estimated of 9.6 million TB cases occurred and 1.5 million death occurred due to TB worldwide.

Conclusion: The present review is an attempt to introduce this disease focusing on the pathophysiology of the disease, the current approaches and the related patents for treatment and the future planning for combating this disease.

Keywords: Tuberculosis therapy, first line treatment, fluorquinolones, second line therapy, diagnosis, new drug.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy